A Novel Duplex Real-Time Reverse-Transcription PCR Assay for the Detection of Influenza A and the Novel Influenza A(H1N1) Strain
2009

New Test for Detecting Influenza A and H1N1

Sample size: 183 publication Evidence: high

Author Information

Author(s): Rebecca J. Rockett, Seweryn Bialasiewicz, David M. Whiley, Cheryl Bletchly, Cassandra E. Faux, Stephen B. Lambert, Graeme R. Nimmo, Michael D. Nissen, Theo P. Sloots

Primary Institution: Queensland Paediatric Infectious Diseases Laboratory, Sir Albert Sakzewski Virus Research Centre, Queensland Children’s Medical Research Institute, Children’s Health Service District, Queensland, Australia

Hypothesis

Can a new duplex real-time PCR assay effectively detect a broad range of influenza A subtypes and specifically identify the H1N1 pandemic strain?

Conclusion

The dFLU-TM assay is sensitive and specific for detecting influenza A, including the H1N1 pandemic strain, in clinical samples.

Supporting Evidence

  • The dFLU-TM assay showed a clinical sensitivity of 94% and specificity of 100% for pre-2009 samples.
  • For 2009 pandemic samples, the assay demonstrated a clinical sensitivity of 95%.
  • The assay targets a highly conserved region of the influenza A matrix gene, enhancing its reliability.

Takeaway

Researchers created a new test that can quickly find different types of flu, including the H1N1 strain, to help doctors treat patients faster.

Methodology

The study developed a duplex RT-PCR assay and compared its results with two existing monoplex RT-PCR assays using clinical samples.

Limitations

Some samples had low viral loads, which may have affected the accuracy of the results.

Participant Demographics

Clinical samples included nasopharyngeal aspirates, swabs, and bronchial wash specimens from different years.

Digital Object Identifier (DOI)

10.3390/v1031204

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication